About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision-making by clinicians, managers, and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
Development of this briefing
This briefing was developed for NICE by the KITEC KHP External Assessment Centre (EAC). The Interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality assured and approved for publication.
Project team
KITEC KHP EAC
Medical Technologies Evaluation Programme, NICE
Peer reviewers and contributors
-
James Clinch, Technical Adviser, KITEC KHP.
-
Elizabeth Morris, Technical Adviser, KITEC KHP.
-
Muralikrishnan Radhakrishnan Kartha, Health Economist, KITEC KHP.
-
Stephen Keevil, Centre Director, KITEC KHP.
-
Cornelius Lewis, Centre Director, KITEC KHP.
Specialist commentators
The following specialist commentators provided comments on a draft of this briefing:
-
Dr Ashley Garner, Principal Clinical Biochemist, Leeds Teaching Hospitals NHS Trust
-
Dr Edmund Lamb, Consultant Clinical Scientist, East Kent Hospitals University NHS Foundation Trust
-
Dr David Milford, Consultant Nephrologist, Birmingham Children's Hospital NHS Foundation Trust
-
Dr Sheetal Bhojani, Paediatric Nephrology Trainee, NHS Greater Glasgow &Clyde